Essia Belarbi

Abstract First isolated in 1953 in Tanzania, the arthritogenic Chikungunya virus (CHIKV) re-emerged globally in 2005, leading to widespread outbreaks. Unlike other arboviruses, CHIKV predominantly induces symptomatic infections (72-96%), marked by fever, myalgia, polyarthralgia, and rash. Although rarely fatal, atypical forms such as encephalopathies can occur. Notably, 75.4% of patients experience persistent arthralgias for up to three years after the acute phase.

Open AccessArticle by Yacouba Sawadogo 1,2,†, Lokman Galal 3,4,†, Essia Belarbi 5, Arsène Zongo 6, Grit Schubert 5, Fabian Leendertz 7, Abdoulie Kanteh 8, Abdul Karim Sesay 8, Annette Erhart 9, Anne-Laure Bañuls 4,10, Zékiba Tarnagda 11, Sylvain Godreuil 3,4,10, Halidou Tinto 12 and Abdoul-Salam Ouedraogo 1,2,6,10,* 1 Departement of Bacteriology and Virology, Souro Sanou University Hospital, Bobo Dioulasso 01 BP 676, Burkina Faso 2 Laboratory of Emerging and Re-emerging Pathogens, School of...